Vasospasm after subarachnoid hemorrhage interest in diffusion-weighted MR imaging

Stroke

Volumn 32, Issue 8, 2001, Pages 1818-1824

  Condette Auliac, S ^a,b   Bracard, Serge ^a   Anxionnat, R ^a   Schmitt, E ^a   Lacour, J C ^a   Braun, M ^a   Meloneto, J ^a   Cordebar, A ^a   Yin, L ^a   Picard, L ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Magnetic resonance imaging, diffusion weighted; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ADULT; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DISEASE MARKER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; VASOSPASM; WHITE MATTER;

EID: 0034888229     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.8.1818     Document Type: Article

References (29)

1. Endovascular treatment of cerebral vasospasm: Assessment of treatment effect by cerebral angiography and transcranial Doppler sonography
2. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage
3. Epidémiologie, étude clinique et anatomopathologie du vasospasme
4. Therapeutic modalities for the management of cerebral vasospasm: Timing of endovascular options
5. Imagerie du vasospasme
6. Doppler transcrânien et vasospasme cérébral
7. SPECT imaging in cerebral vasospasm following subarachnoid hemorrhage
8. Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl propyleneamine oxime (HM-PAO) tomoscintigraphy
9. Determination of irreversible ischemia by xenon enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm
10. Discrepancies between cerebral perfusion and metabolism after subarachnoid haemorrhage: A magnetic resonance approach
11. Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage
12. Diffusion MR imaging during acute subarachnoid hemorrhage in rats
13. Hemorrhagic and non hemorrhagic stroke: Diagnosis with diffusion weighted echo-planar MR imaging
14. MRI features of intracerebral hemorrhage within 2 hours from symptom onset
15. A standardized MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage
16. Diffusion and perfusion with MR imaging
17. Diffusion MRI in patients with transient ischemic attacks
18. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging
19. Resolution of early diffusion-weighted and FLAIR MRI abnormalities in a patient with TIA
20. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal ischemia in rats
21. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats
22. Serial MRI after transient focal ischemia in rats: Dynamics of tissue injury, blood-brain barrier damage, and edema formation
23. Histopathologic correlates of temporal diffusion changes in a rat model of cerebral hypoxia/ischemia
24. The relationship between the apparent diffusion coefficient measured by magnetic resonance imaging, anoxic depolarization and glutamate efflux during experimental cerebral ischemia
25. Periictal diffusion-weighted imaging in a case of lesional epilepsy
26. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia
27. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water
28. Diffusion-weighted MR imaging in acute stroke: Theoretical considerations and clinical applications
29. Rapid monitoring of diffusion, DC potential, and blood oxygenation changes during global ischemia: Effects of hypoglycemia, hyperglycemia, and TTX